Phase 2 Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older (male or female)
- You are willing to sign a consent form agreeing to take part
- Your doctors expect you to live for more than 6 months
- You have been newly diagnosed with advanced (Stage IV) melanoma that started in the skin, on the hands or feet (acral), or from an unknown location, confirmed by a tissue biopsy
- Your melanoma has spread to between 1 and 5 spots outside the brain, seen on CT and PET-CT scans, and cannot be removed by surgery
- You may also have the original melanoma site and/or up to 4 nearby skin spread spots, as long as the total number of spots does not exceed 5
- If you had surgery to relieve urgent symptoms (such as a bowel blockage), you may still qualify as long as no more than one spot was removed and 5 or fewer spots remain
- At least one of your cancer spots can be measured on scans using standard measurement guidelines
- There is no sign of melanoma spread to the brain (checked by MRI, or CT scan if MRI is not suitable for you)
- All of your cancer spots can be treated with a precise, high-dose form of targeted radiation therapy (SBRT) at the required dose level
- Your specialist doctor has decided you are well enough to receive immunotherapy treatment
- Your general health and ability to carry out daily activities meets a standard score of 0–2 (meaning you are fully active to capable of basic self-care) (confirm with trial site)
- If you could become pregnant, you must have a negative blood pregnancy test within 7 days of being assigned to a treatment group
Who may not be able to join:
- Your melanoma started in the eye or on the mucous membranes (such as inside the mouth or nose)
- You have serious or unstable health conditions that could affect your safety or ability to participate
- You need radiotherapy urgently and immediately for a serious complication (such as pressure on the spinal cord or rapidly worsening symptoms)
- You have previously had radiotherapy for Stage IV (advanced/spread) melanoma
- Not all of your cancer spots can be safely treated with the targeted radiation therapy (SBRT), as decided by your radiation specialist
- You have previously had drug treatment (such as chemotherapy or immunotherapy) for melanoma, unless it was given as a preventative treatment at an earlier, less advanced stage
- You have any reason why you cannot safely receive the planned immunotherapy drugs
- You have melanoma that has spread to the liver AND you have moderate or severe liver problems
- You have a history of another cancer, unless you have been cancer-free for at least 1 year, have been fully treated, and have a low chance of it coming back
- You are currently pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Angela Hong, Melanoma Institute Australia
Phone: +61 2 9911 7296
Australian sites
+612 9911 7200
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
4 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Overall survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.